Swiss Economicblogs.org
Novartis launched a new strategy in sub-Saharan Africa in 2019. Sales people will no longer be incentivised by sales targets but rather by patients reached. Reuters / Baz Ratner Novartis has said it wants everyone in the world to be able to access its products, even multi-million-dollar gene therapies. Can its experiment work? Five years ago, Swiss pharma firm Novartis did something no one else in the industry had ever done. It set out to rigorously evaluate whether...
Read More »Can Novartis really make its medicines available to everyone?
